BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 21420494)

  • 1. MeCP2 is required for global heterochromatic and nucleolar changes during activity-dependent neuronal maturation.
    Singleton MK; Gonzales ML; Leung KN; Yasui DH; Schroeder DI; Dunaway K; LaSalle JM
    Neurobiol Dis; 2011 Jul; 43(1):190-200. PubMed ID: 21420494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MeCP2 Levels Regulate the 3D Structure of Heterochromatic Foci in Mouse Neurons.
    Ito-Ishida A; Baker SA; Sillitoe RV; Sun Y; Zhou J; Ono Y; Iwakiri J; Yuzaki M; Zoghbi HY
    J Neurosci; 2020 Nov; 40(45):8746-8766. PubMed ID: 33046553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATRX Contributes to MeCP2-Mediated Pericentric Heterochromatin Organization during Neural Differentiation.
    Marano D; Fioriniello S; Fiorillo F; Gibbons RJ; D'Esposito M; Della Ragione F
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31671722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MeCP2 functions largely cell-autonomously, but also non-cell-autonomously, in neuronal maturation and dendritic arborization of cortical pyramidal neurons.
    Kishi N; Macklis JD
    Exp Neurol; 2010 Mar; 222(1):51-8. PubMed ID: 20025874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic changes in Histone H3 lysine 9 acetylation localization patterns during neuronal maturation require MeCP2.
    Thatcher KN; LaSalle JM
    Epigenetics; 2006; 1(1):24-31. PubMed ID: 17464364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease modeling using embryonic stem cells: MeCP2 regulates nuclear size and RNA synthesis in neurons.
    Yazdani M; Deogracias R; Guy J; Poot RA; Bird A; Barde YA
    Stem Cells; 2012 Oct; 30(10):2128-39. PubMed ID: 22865604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome.
    Peddada S; Yasui DH; LaSalle JM
    Hum Mol Genet; 2006 Jun; 15(12):2003-14. PubMed ID: 16682435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reciprocal co-regulation of EGR2 and MECP2 is disrupted in Rett syndrome and autism.
    Swanberg SE; Nagarajan RP; Peddada S; Yasui DH; LaSalle JM
    Hum Mol Genet; 2009 Feb; 18(3):525-34. PubMed ID: 19000991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions.
    Kishi N; Macklis JD
    Mol Cell Neurosci; 2004 Nov; 27(3):306-21. PubMed ID: 15519245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neural development of methyl-CpG-binding protein 2 null embryonic stem cells: a system for studying Rett syndrome.
    Okabe Y; Kusaga A; Takahashi T; Mitsumasu C; Murai Y; Tanaka E; Higashi H; Matsuishi T; Kosai K
    Brain Res; 2010 Nov; 1360():17-27. PubMed ID: 20816763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mecp2 deficiency leads to delayed maturation and altered gene expression in hippocampal neurons.
    Smrt RD; Eaves-Egenes J; Barkho BZ; Santistevan NJ; Zhao C; Aimone JB; Gage FH; Zhao X
    Neurobiol Dis; 2007 Jul; 27(1):77-89. PubMed ID: 17532643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice.
    Chen RZ; Akbarian S; Tudor M; Jaenisch R
    Nat Genet; 2001 Mar; 27(3):327-31. PubMed ID: 11242118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of MeCP2 in immature neurons leads to impaired network integration.
    Sun Y; Gao Y; Tidei JJ; Shen M; Hoang JT; Wagner DF; Zhao X
    Hum Mol Genet; 2019 Jan; 28(2):245-257. PubMed ID: 30277526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methyl CpG-binding proteins induce large-scale chromatin reorganization during terminal differentiation.
    Brero A; Easwaran HP; Nowak D; Grunewald I; Cremer T; Leonhardt H; Cardoso MC
    J Cell Biol; 2005 Jun; 169(5):733-43. PubMed ID: 15939760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets.
    Jordan C; Li HH; Kwan HC; Francke U
    BMC Med Genet; 2007 Jun; 8():36. PubMed ID: 17584923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2.
    Giacometti E; Luikenhuis S; Beard C; Jaenisch R
    Proc Natl Acad Sci U S A; 2007 Feb; 104(6):1931-6. PubMed ID: 17267601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MeCP2 dependent heterochromatin reorganization during neural differentiation of a novel Mecp2-deficient embryonic stem cell reporter line.
    Bertulat B; De Bonis ML; Della Ragione F; Lehmkuhl A; Milden M; Storm C; Jost KL; Scala S; Hendrich B; D'Esposito M; Cardoso MC
    PLoS One; 2012; 7(10):e47848. PubMed ID: 23112857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The protocadherins, PCDHB1 and PCDH7, are regulated by MeCP2 in neuronal cells and brain tissues: implication for pathogenesis of Rett syndrome.
    Miyake K; Hirasawa T; Soutome M; Itoh M; Goto Y; Endoh K; Takahashi K; Kudo S; Nakagawa T; Yokoi S; Taira T; Inazawa J; Kubota T
    BMC Neurosci; 2011 Aug; 12():81. PubMed ID: 21824415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MeCP2, A Modulator of Neuronal Chromatin Organization Involved in Rett Syndrome.
    Martínez de Paz A; Ausió J
    Adv Exp Med Biol; 2017; 978():3-21. PubMed ID: 28523538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rett syndrome-causing mutations compromise MeCP2-mediated liquid-liquid phase separation of chromatin.
    Wang L; Hu M; Zuo MQ; Zhao J; Wu D; Huang L; Wen Y; Li Y; Chen P; Bao X; Dong MQ; Li G; Li P
    Cell Res; 2020 May; 30(5):393-407. PubMed ID: 32111972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.